Anderson JL, Morrow DA (2017) Acute Myocardial Infarction. N Engl J Med 376(21):2053–2064. https://doi.org/10.1056/NEJMra1606915
Article CAS PubMed Google Scholar
Lv J, Ni L, Liu K et al (2021) Clinical Characteristics, Prognosis, and Gender Disparities in Young Patients With Acute Myocardial Infarction. Front Cardiovasc Med 8:720378. https://doi.org/10.3389/fcvm.2021.720378
Article PubMed PubMed Central Google Scholar
Zhou Z, Liu C, Xu S et al (2022) Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model. Basic Res Cardiol 117(1):34. https://doi.org/10.1007/s00395-022-00939-2
Article CAS PubMed Google Scholar
Gupta MC, Singh MM, Singh R (1983) Ventricular fibrillation in acute myocardial infarction. Angiology 34(7):440–444. https://doi.org/10.1177/000331978303400703
Article CAS PubMed Google Scholar
Tran HV, Gore JM, Darling CE et al (2018) Hyperglycemia and risk of ventricular tachycardia among patients hospitalized with acute myocardial infarction. Cardiovasc Diabetol 17(1):136. https://doi.org/10.1186/s12933-018-0779-8
Article CAS PubMed PubMed Central Google Scholar
Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361(9351):13–20. https://doi.org/10.1016/s0140-6736(03)12113-7
Hong CL, Chen SC, Hu TY, Lin ZH, Chen PY, Lin ZJ, Xie LX, Liu YH, He PC (2024) Prognostic value of optical flow ratio among patients with coronary artery disease after percutaneous coronary treatment: A hospital-based retrospective cohort investigation. Cardiovasc Innov Appl 9(1):979. https://doi.org/10.15212/CVIA.2024.0012
Elhendy A, Chapman S, Porter TR, Windle J (2005) Association of myocardial ischemia with mortality and implantable cardioverter-defibrillator therapy in patients with coronary artery disease at risk of arrhythmic death. J Am Coll Cardiol 46(9):1721–1726. https://doi.org/10.1016/j.jacc.2005.04.065
Gheeraert PJ, De Buyzere ML, Taeymans YM et al (2006) Risk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis. Eur Heart J 27(21):2499–2510. https://doi.org/10.1093/eurheartj/ehl218
Bovo E, Mazurek SR, Zima AV (2018) Oxidation of ryanodine receptor after ischemia-reperfusion increases propensity of Ca(2+) waves during β-adrenergic receptor stimulation. Am J Physiol Heart Circ Physiol 315(4):H1032–H1040. https://doi.org/10.1152/ajpheart.00334.2018
Article CAS PubMed PubMed Central Google Scholar
Zeymer U (2019) Diagnosis and initial management of acute myocardial infarction. MMW Fortschr Med 161(4):34–36. https://doi.org/10.1007/s15006-019-0223-3
Wang CG, Qin XC, Nie SP et al (2019) C-reactive protein as a predictor of malignant ventricular arrhythmias in non-ST elevation myocardial infarction. J Geriatr Cardiol 16(8):614–620. https://doi.org/10.11909/j.issn.1671-5411.2019.08.007
Article CAS PubMed PubMed Central Google Scholar
Benham JL, Booth JE, Sigal RJ et al (2021) Systematic review and meta-analysis: SGLT2 inhibitors, blood pressure and cardiovascular outcomes. Int J Cardiol Heart Vasc 33:100725. https://doi.org/10.1016/j.ijcha.2021.100725
Article PubMed PubMed Central Google Scholar
Treewaree S, Kulthamrongsri N, Owattanapanich W, Krittayaphong R (2023) Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systematic review and meta-analysis. Front Cardiovasc Med 10:1046194. https://doi.org/10.3389/fcvm.2023.1046194
Article CAS PubMed PubMed Central Google Scholar
Barbarawi M, Al-Abdouh A, Barbarawi O et al (2022) SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis. Heart Fail Rev 27(3):951–960. https://doi.org/10.1007/s10741-021-10083-z
Article CAS PubMed Google Scholar
Lassen MCH, Ostrominski JW, Inzucchi SE et al (2024) Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trial. Eur J Heart Fail 26(7):1539–1548. https://doi.org/10.1002/ejhf.3269
Article CAS PubMed Google Scholar
Sai M, Lili H, Qingjuan Z, Guorui Z, Yifang G (2023) Canagliflozin regulates ferroptosis, potentially via activating AMPK/PGC-1α/Nrf2 signaling in HFpEF rats. Cardiovascular Innovations and Applications 7(1):987
Lahnwong C, Palee S, Apaijai N et al (2020) Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury. Cardiovasc Diabetol 19(1):91. https://doi.org/10.1186/s12933-020-01066-9
Article CAS PubMed PubMed Central Google Scholar
Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined–a consensus document of the joint european society of cardiology/american college of cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36(3):959–969. https://doi.org/10.1016/s0735-1097(00)00804-4
Article CAS PubMed Google Scholar
Al-Khatib SM, Stevenson WG, Ackerman MJ et al (2018) 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the american college of cardiology/american heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol 72(14):e91–e220. https://doi.org/10.1016/j.jacc.2017.10.054
Mehta RH, Yu J, Piccini JP et al (2012) Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial). Am J Cardiol 109(6):805–812. https://doi.org/10.1016/j.amjcard.2011.10.043
Sun L, Han B, Wang Y et al (2023) A new scoring system for predicting ventricular arrhythmia risk in patients with acute myocardial infarction. Clin Interv Aging 18:283–292. https://doi.org/10.2147/cia.S395121
Article CAS PubMed PubMed Central Google Scholar
Albanese M, Alpaslan K, Ouarrak T et al (2018) In-hospital major arrhythmias, arrhythmic death and resuscitation after successful primary percutaneous intervention for acute transmural infarction: a retrospective single-centre cohort study. BMC Cardiovasc Disord 18(1):116. https://doi.org/10.1186/s12872-018-0851-z
Article CAS PubMed PubMed Central Google Scholar
Mehta RH, Starr AZ, Lopes RD et al (2009) Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA 301(17):1779–1789. https://doi.org/10.1001/jama.2009.600
Article CAS PubMed Google Scholar
Garcia R, Marijon E, Karam N et al (2022) Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study. Eur Heart J 43(47):4887–4896. https://doi.org/10.1093/eurheartj/ehac579
Masuda M, Nakatani D, Hikoso S et al (2016) Clinical impact of ventricular tachycardia and/or fibrillation during the acute phase of acute myocardial infarction on in-hospital and 5-year mortality rates in the percutaneous coronary intervention era. Circ J 80(7):1539–1547. https://doi.org/10.1253/circj.CJ-16-0183
Arauna D, Chandia E, Nova-Lamperti E et al (2025) Platelet content from acute myocardial infarction patients: Elevated levels of IL-6 and IL-8 and their impact on endothelial nitric oxide production. Atherosclerosis 403:119119. https://doi.org/10.1016/j.atherosclerosis.2025.119119
Article CAS PubMed Google Scholar
Yang SB, Zhao HW (2025) Associations between albumin/neutrophil-to-lymphocyte ratio score and new-onset atrial fibrillation in patients with acute myocardial infarction undergoing PCI. J Inflamm Res 18:61–71. https://doi.org/10.2147/jir.S500743
Comments (0)